Cartesian Therapeutics In Share Price (NASDAQ: RNAC)
$10.04
Last updated on
Check the interactive Cartesian Therapeutics In Stock chart to analyse performance
Cartesian Therapeutics In stock performance
as on August 30, 2025 at 1:29 am IST
- Today's Low:$10.04Today's High:$10.29
0.0%
Downside
Day's Volatility :2.43%
Upside
2.43%
- 52 Weeks Low:$8.4652 Weeks High:$26.50
15.74%
Downside
52 Weeks Volatility :68.08%
Upside
62.11%
Cartesian Therapeutics In Stock Returns
Cartesian Therapeutics In Key Stats
Check Cartesian Therapeutics In key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Cartesian Therapeutics In Stock including INR - Dollar returns
The Cartesian Therapeutics In stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Cartesian Therapeutics In investment value today
Current value as on today
₹77,204
Returns
Returns from Cartesian Therapeutics In Stock
Dollar Returns*
₹5,284 (+5.28%)
Indian investors sentiment towards Cartesian Therapeutics In Stock
Global Institutional Holdings in Cartesian Therapeutics In
Name
Holdings %
FMR Inc
9.00%
MPM Oncology Impact Management LP
2.64%
BlackRock Inc
2.59%
Siren, L.L.C.
2.17%
Vanguard Group Inc
1.91%
Erste Asset Management GmbH
1.00%
Analyst Recommendation on Cartesian Therapeutics In Stock
Buy
90%Buy
9%Hold
0%Sell
Based on 11 Wall street analysts offering stock ratings for Cartesian Therapeutics In(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Cartesian Therapeutics In Share Price Target
What analysts predicted
Upside of 262.83%
Target:
$36.43
Current:
$10.04
Cartesian Therapeutics In share price target is $36.43, a slight Upside of 262.83% compared to current price of $10.04 as per analysts' prediction.
Cartesian Therapeutics In Stock Insights
Price Movement
In the last 7 days, RNAC stock has moved down by -9.5%Decreasing Revenue
Revenue is down for the last 2 quarters, 1.1M → 298.0K (in $), with an average decrease of 72.9% per quarterIncreasing Net Profit
Netprofit is up for the last 2 quarters, -17.71M → 15.88M (in $), with an average increase of 211.5% per quarterRNAC vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 97.1%Price to Sales
ForRNAC every $1 of sales, investors are willing to pay $241.9, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.
Cartesian Therapeutics In Financials
Cartesian Therapeutics In Technicals Summary
Sell
Neutral
Buy
Cartesian Therapeutics In is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Cartesian Therapeutics In Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| -17.6% | -41.94% | -22.56% | 449.19% | 783.48% |
 | 6.48% | -15.2% | -50.31% | -3.3% | -2.01% |
| 1.77% | 24.81% | 62.78% | 79.11% | 29.69% |
 | -14.45% | -19.13% | -17.84% | 34.68% | 41.87% |
 | 13.79% | 83.28% | 75.87% | 111.28% | 242.25% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| 1.98 | NA | 0.0 | -1.11 | -70.29 | -0.14 | NA | -0.1 |
| 14.6 | 14.6 | 1.2 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.73 | -0.05 | -0.01 | NA | 34.32 |
| 27.86 | 27.86 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $267.3M | 783.48% | 1.98 | 0.0% |
| Buy | $61.4B | -2.01% | 14.6 | 31.37% |
| NA | $36.5B | 29.69% | NA | -3.89% |
| Buy | $100.5B | 41.87% | 27.86 | 31.86% |
| Buy | $59.5B | 242.25% | NA | -12.96% |
About Cartesian Therapeutics In
Key Management of Cartesian Therapeutics In
Important FAQs about investing in RNAC Stock from India :
What is Cartesian Therapeutics In share price today?
Cartesian Therapeutics In share price today is $10.04 as on at the close of the market. Cartesian Therapeutics In share today touched a day high of $10.29 and a low of $10.04.
What is the 52 week high and 52 week low for Cartesian Therapeutics In share?
Cartesian Therapeutics In share touched a 52 week high of $26.50 and a 52 week low of $8.46. Cartesian Therapeutics In stock price today i.e. is closed at $10.04, lower by 62.11% versus the 52 week high.
How to invest in Cartesian Therapeutics In Stock (RNAC) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Cartesian Therapeutics In on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cartesian Therapeutics In Shares that will get you 0.1494 shares as per Cartesian Therapeutics In share price of $10.04 per share as on August 30, 2025 at 1:29 am IST.
What is the minimum amount required to buy Cartesian Therapeutics In Stock (RNAC) from India?
Indian investors can start investing in Cartesian Therapeutics In (RNAC) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Cartesian Therapeutics In stock (as per the Rupee-Dollar exchange rate as on August 31, 2025).
Based on Cartesian Therapeutics In share’s latest price of $10.04 as on August 30, 2025 at 1:29 am IST, you will get 0.9960 shares of Cartesian Therapeutics In. Learn more about
fractional shares .
What are the returns that Cartesian Therapeutics In has given to Indian investors in the last 5 years?
Cartesian Therapeutics In stock has given 783.48% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
- Webs Defined Volatility Xle
$24.99
-0.04%
- United States 12 Month Natur
$7.81
+1.83%
- F/m U S T Inl-p S (tips) Etf
$50.14
+0.06%
- Pgim Jennison Focused Growth Etf
$105.89
-1.37%
Hitek Global Inc$1.49
+1.36%
Vaneck Vectors Preferred Secs Ex Finls Etf$17.68
-0.73%
Marker Therapeutics Inc$0.93
+3.33%
- Cambria Value And Momentum Etf
$32.55
+0.25%